Search Tag: Seraph 10

ICU Management

Michael-porter-of-harvard-business-school-has-joined-the-board-of-directors-of-exthera-medical

2020 29 Sep

Michael Porter, Ph.D., has joined the board of directors of ExThera Medical Corporation, a privately held medical technology company focused on the therapeutic reduction of drug-resistant pathogens and sepsis mediators in whole blood. ExThera’s  Seraph® 100 Microbind® Affinity Blood Filter  (Seraph 100) has a CE Mark in Europe for the treatment...Read more